rediff.com

Strides Pharma Gets USFDA Nod for Generic Pain Relief Drug

Share on:

By Rediff Money Desk, New Delhi   Jan 20, 2025 18:04

Strides Pharma Science's Singapore arm receives USFDA approval for its generic Acetaminophen and Ibuprofen tablets, offering a dual-action pain relief option for a broader patient base.
Strides Pharma Gets USFDA Nod for Generic Pain Relief Drug
Photograph: Yves Herman/Reuters
New Delhi, Jan 20 (PTI) Strides Pharma Science Ltd on Monday said its wholly-owned arm Strides Pharma Global Pte. Limited, Singapore, has received approval from the US health regulator for its generic pain-relieving Acetaminophen and Ibuprofen tablets.

The approval by the US Food & Drug Administration (USFDA) is for generic over-the-counter (OTC) Acetaminophen and Ibuprofen tablets of strength 125 mg /250 mg, Strides Pharma Science said in a statement.

The product is bioequivalent to the reference listed drug (RLD), Advil Dual Action with Acetaminophen, 125 mg /250 mg (OTC), of Haleon US Holdings LLC, it added.

"The addition of the Acetaminophen and Ibuprofen tablets, 125 mg /250 mg (OTC) will significantly enhance our existing portfolio of OTC products. By offering a dual-action pain relief option, we aim to cater to a broader patient base, providing effective and accessible solutions for pain management," the company said.

Acetaminophen and Ibuprofen tablets will be manufactured at the company's flagship facility in KRSG, Bengaluru, it added.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

More »

Moneywiz Live!